{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:22Z","timestamp":1761518962795},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>OBJECTIVE: Hypoparathyroidism is a disorder in which parathyroid hormone is deficient in the circulation due most often to immunological destruction of the parathyroids or to their surgical removal. The objective of this work was to define the abnormalities in skeletal microstructure as well as to establish the potential efficacy of PTH(1-84) replacement in this disorder. SUBJECTS AND METHODS: Standard histomorphometric and \u00b5CT analyses were performed on iliac crest bone biopsies obtained from patients with hypoparathyroidism. Participants were treated with PTH(1-84) for two years. RESULTS: Bone density was increased and skeletal features reflected the low turnover state with greater BV\/TV, Tb. Wi and Ct. Wi as well as suppressed MS and BFR\/BS as compared to controls. With PTH(1-84), bone turnover and bone mineral density increased in the lumbar spine. Requirements for calcium and vitamin D fell while serum and urinary calcium concentrations did not change. CONCLUSION: Abnormal microstructure of the skeleton in hypoparathyroidism reflects the absence of PTH. Replacement therapy with PTH has the potential to correct these abnormalities as well as to reduce the requirements for calcium and vitamin D.<\/jats:p>","DOI":"10.1590\/s0004-27302010000200019","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T09:04:04Z","timestamp":1273741444000},"page":"220-226","source":"Crossref","is-referenced-by-count":41,"title":["Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement"],"prefix":"10.1590","volume":"54","author":[{"given":"Mishaela R.","family":"Rubin","sequence":"first","affiliation":[{"name":"Columbia University,  Estados Unidos"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[{"name":"Columbia University,  Estados Unidos"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen P","year":"1990","journal-title":"N Engl J Med."},{"key":"ref2","series-title":"Conn's Current Therapy 2008","first-page":"634","volume-title":"Primary hyperparathyroidism and hypoparathyroidism","author":"Bilezikian JP","year":"2008","edition":"1"},{"key":"ref3","series-title":"editors. Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"354","volume-title":"Hypoparathyroidism and pseudohypoparathyroidism","author":"Rubin MR","year":"2008"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice: Hypoparathyroidism","volume":"359","author":"Shoback D.","year":"2008","journal-title":"N Engl J Med."},{"key":"ref5","first-page":"3792","article-title":"A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism","volume":"84","author":"Sunthornthepvarakul T","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-0-387-72005-0_4","article-title":"DiGeorge syndrome\/velocardiofacial syndrome: the chromosome 22q11.2 deletion syndrome","volume":"601","author":"Sullivan KE","year":"2007","journal-title":"Adv Exp Med Biol."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ecl.2009.01.001","article-title":"Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism","volume":"38","author":"Brown EM","year":"2009","journal-title":"Endocrinol Metab Clin North Am."},{"key":"ref8","first-page":"1617","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","volume":"76","author":"Abugassa S","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"ref9","first-page":"2135","article-title":"Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism","volume":"80","author":"Fujiyama K","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI110570","article-title":"Differential effects of endocrine dysfunction on the axial and the appendicular skeleton","volume":"69","author":"Seeman E","year":"1982","journal-title":"J Clin Invest."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000441-199508000-00003","article-title":"Hypoparathyroidism counteracts risk factors for osteoporosis","volume":"310","author":"Touliatos JS","year":"1995","journal-title":"Am J Med Sci."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin MR","year":"2008","journal-title":"J Bone Miner Res."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg SJ","year":"1989","journal-title":"J Bone Miner Res."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin MR","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three-dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin MR","year":"2010","journal-title":"Bone","ISSN":"http:\/\/id.crossref.org\/issn\/8756-3282","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(78)92702-2","article-title":"Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol","volume":"2","author":"Christiansen C","year":"1978","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.1987.272","article-title":"Calcium-regulating hormones and the kidney","volume":"32","author":"Kurokawa K","year":"1987","journal-title":"Kidney Int."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jcem-18-3-246","article-title":"Hypocalcemic hypercalciuria during vitamin D and dihydrotachysterol therapy of hypoparathyroidism","volume":"18","author":"Litvak J","year":"1958","journal-title":"J Clin Endocrinol Metab."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer KK","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer KK","year":"1996","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref21","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer KK","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"ref22","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","author":"Rubin MR","year":"2009","journal-title":"Osteoporosis Int."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer RM","year":"2001","journal-title":"N Engl J Med."}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v54n2\/19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T15:49:35Z","timestamp":1495813775000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302010000200019&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0004-27302010000200019"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302010000200019","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}